Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma
Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor
cells, either by killing the cells or by stopping them from dividing. It is not yet known
whether giving paclitaxel together with carboplatin is more effective than giving
temozolomide alone in treating patients with melanoma.
PURPOSE: This phase II trial is studying the side effects and how well giving paclitaxel
together with carboplatin or giving temozolomide alone works in treating patients with stage
IV melanoma.